Magnesium for treating sickle cell disease.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2017-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD011358.pub2PMID 28409830PMCID PMC6478130
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Magnesium for treating sickle cell disease.

  2019cited by this paper
• Red Blood Cell and Serum Magnesium Levels Among Children and Adolescents With Sickle Cell Anemia

  2018cited by this paper
• Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module

  2017cited by this paper
• Red blood cell transfusions during sickle cell anemia vaso‐occlusive crises: a report from the magnesium in crisis (MAGiC) study

  2017cited by this paper
• Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease

  2016cited by this paper
• Intravenous magnesium not effective in sickle cell pain crises

  2016cited by this paper
• Higher Dose of Opioids in the Emergency Department and Earlier Initiation of Oral Opioids after Hospitalization Are Associated with Shorter Length of Stay in Children with Sickle Cell Disease Treated for Acute Pain

  2015cited by this paper
• MAGiC: VOC remains but kids with SCA appear.

  2015cited by this paper
• Sickle cell disease.

  2014cited by this paper
• Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

  2014cited by this paper
• The Impact of an Acute Vaso-Occlusive Crisis on Patient Reported Outcomes: The Magic Study

  2014cited by this paper
• A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.

  2014cited by this paper
• Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus (儿童与青少年1型糖尿病患者的镁浓度与HbA1c之间的关系)

  2014cited by this paper
• Intravenous magnesium for pediatric sickle cell vaso‐occlusive crisis: Methodological issues of a randomized controlled trial

  2014cited by this paper
• Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study.

  2014cited by this paper
• Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus.

  2014cited by this paper
• Intravenous Magnesium Sulfate for Vaso-occlusive Episodes in Sickle Cell Disease

  2013cited by this paper
• Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

  2013cited by this paper
• Hemopexin Therapy Improves Cardiovascular Function by Preventing Heme-Induced Endothelial Toxicity in Mouse Models of Hemolytic Diseases

  2013cited by this paper
• Sickle cell disease related mortality in the United States (1999–2009)

  2013cited by this paper
• Reconstructing sickle cell disease: A data‐based analysis of the “hyperhemolysis paradigm” for pulmonary hypertension from the perspective of evidence‐based medicine

  2011cited by this paper
• The effects of hydroxycarbamide and magnesium on haemoglobin SC disease: results of the multi‐centre CHAMPS trial

  2011cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2011cited by this paper
• Thrombosis and Sickle Cell Disease

  2011cited by this paper
• Abnormal modulation of cell protective systems in response to ischemic/reperfusion injury is important in the development of mouse sickle cell hepatopathy

  2011cited by this paper
• Acute care utilization and rehospitalizations for sickle cell disease.

  2010cited by this paper
• Sickle-cell disease

  2010cited by this paper
• The course and correlates of high hospital utilization in sickle cell disease: Evidence from a large, urban Medicaid managed care organization

  2009cited by this paper
• Effects of Hydroxyurea (HU) and Magnesium Pidolate (Mg) in Hemoglobin SC Disease (HbSC): the “CHAMPS” Trial.

  2009cited by this paper
• Global epidemiology of haemoglobin disorders and derived service indicators.

  2008cited by this paper
• Endothelin receptor antagonism prevents hypoxia-induced mortality and morbidity in a mouse model of sickle-cell disease.

  2008cited by this paper
• Newborn screening for sickle cell disease in the Republic of Benin

  2008cited by this paper
• Novel inhibitors of the Gardos channel for the treatment of sickle cell disease.

  2008cited by this paper
• Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.

  2008cited by this paper
• Cytokines and plasma factors in sickle cell disease

  2007cited by this paper
• Phase I study of magnesium pidolate in combination with hydroxycarbamide for children with sickle cell anaemia

  2007cited by this paper
• Regulation of K-Cl cotransport by protein phosphatase 1alpha in mouse erythrocytes.

  2006cited by this paper
• Regulation of K–Cl cotransport by protein phosphatase 1α in mouse erythrocytes

  2006cited by this paper
• Abnormal regulation of Mg2+ transport via Na/Mg exchanger in sickle erythrocytes.

  2005cited by this paper
• Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease.

  2005cited by this paper
• Epilepsy In Children, 2nd Edition

  2005cited by this paper
• Serum ionized magnesium levels and ionized calcium‐to‐magnesium ratios in adult patients with sickle cell anemia

  2004cited by this paper
• The effect of magnesium on length of stay for pediatric sickle cell pain crisis.

  2004cited by this paper
• Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis.

  2004cited by this paper
• The intriguing contribution of white blood cells to sickle cell disease - a red cell disorder.

  2004cited by this paper
• An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy

  2003cited by this paper
• Hypercoagulability in sickle cell disease: a curious paradox.

  2003cited by this paper
• ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.

  2003cited by this paper
• Inhaled nitric oxide protects transgenic SAD mice from sickle cell disease-specific lung injury induced by hypoxia/reoxygenation.

  2003cited by this paper
• Magnesium: nutrition and metabolism.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Meta-analyses involving cross-over trials: methodological issues.

  2002cited by this paper
• Treatment with NS3623, a novel Cl-conductance blocker, ameliorates erythrocyte dehydration in transgenic SAD mice: a possible new therapeutic approach for sickle cell disease.

  2001cited by this paper
• K-Cl cotransport modulation by intracellular Mg in erythrocytes from mice bred for low and high Mg levels.

  2001cited by this paper
• Role of free radicals in the pathogenesis of acute chest syndrome in sickle cell disease

  2001cited by this paper
• Inherited haemoglobin disorders: an increasing global health problem.

  2001cited by this paper
• The Faces Pain Scale – Revised: toward a common metric in pediatric pain measurement

  2001cited by this paper
• Modulation of endothelial cell activation in sickle cell disease: a pilot study.

  2001cited by this paper
• The management of pain in sickle cell disease.

  2000cited by this paper
• The acute chest syndrome of sickle cell disease.

  2000cited by this paper
• Magnesium. An update on physiological, clinical and analytical aspects.

  2000cited by this paper
• Mg 2 1 -induced endothelium-dependent relaxation of blood vessels and blood pressure lowering: role of NO

  2000cited by this paper
• Oral magnesium pidolate: effects of long‐term administration in patients with sickle cell disease

  2000cited by this paper
• Acute chest syndrome of sickle cell disease.

  2000cited by this paper
• The role of cytokines in sickle cell disease

  2000cited by this paper
• Serum zinc, copper and magnesium in sickle cell disease at Ibadan, south western Nigeria.

  1999cited by this paper
• Mouse K-Cl cotransporter KCC1: cloning, mapping, pathological expression, and functional regulation.

  1999cited by this paper
• Formation of dense erythrocytes in SAD mice exposed to chronic hypoxia: evaluation of different therapeutic regimens and of a combination of oral clotrimazole and magnesium therapies.

  1999cited by this paper
• Magnesium deficiency: a cause of heterogeneous disease in humans.

  1998cited by this paper
• Membrane phospholipid asymmetry in human thalassemia.

  1998cited by this paper
• Role of magnesium in the pathogenesis and treatment of migraines.

  1998cited by this paper
• Magnesium Deficiency: A Cause of Heterogenous Disease in Humans

  1998cited by this paper
• cDNA Cloning and Functional Characterization of the Mouse Ca2+-gated K+ Channel, mIK1

  1998cited by this paper
• Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.

  1997cited by this paper
• Modulation of erythrocyte potassium chloride cotransport, potassium content, and density by dietary magnesium intake in transgenic SAD mouse.

  1996cited by this paper
• Hypocalcaemia and chronic alcohol intoxication: Transient hypoparathyroidism secondary to magnesium deficiency

  1996cited by this paper
• Sickle cell disease.

  1996cited by this paper
• Nutrition in short-bowel syndrome.

  1996cited by this paper
• Sulfhydryl oxidation and activation of red cell K(+)-Cl- cotransport in the transgenic SAD mouse.

  1995cited by this paper
• Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

  1995cited by this paper
• Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease

  1995cited by this paper
• Disorders of magnesium metabolism.

  1995cited by this paper
• Treatment with oral clotrimazole blocks Ca(2+)-activated K+ transport and reverses erythrocyte dehydration in transgenic SAD mice. A model for therapy of sickle cell disease.

  1994cited by this paper
• Dietary magnesium, lung function, wheezing, and airway hyperreactivity in a random adult population sample.

  1994cited by this paper
• Mortality in sickle cell disease. Life expectancy and risk factors for early death.

  1994cited by this paper
• Hypermagnesemic pseudocoma.

  1993cited by this paper
• Effect of cell age and phenylhydrazine on the cation transport properties of rabbit erythrocytes

  1993cited by this paper
• Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives.

  1993cited by this paper
• Deoxygenation-induced cation fluxes in sickle cells. III. Cation selectivity and response to pH and membrane potential.

  1993cited by this paper
• Erythrocyte and plasma magnesium in sickle-cell anaemia.

  1990cited by this paper
• Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease.

  1989cited by this paper
• Magnesium and the lungs.

  1988cited by this paper
• Magnesium.

  1987cited by this paper
• Deoxygenation inhibits the volume-stimulated, Cl(-)-dependent K+ efflux in SS and young AA cells: a cytosolic Mg2+ modulation.

  1987cited by this paper
• Inhibition of K transport by divalent cations in sickle erythrocytes.

  1987cited by this paper
• Regulation of erythrocyte cation and water content in sickle cell anemia.

  1986cited by this paper
• The magnesium dependence of sodium‐pump‐mediated sodium—potassium and sodium—sodium exchange in intact human red cells

  1981cited by this paper
• Magnesium-induced bradycardia.

  1976cited by this paper
• Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

  1975cited by this paper
• Treatment of sickle-cell anemia.

  1963cited by this paper

• Hereditary Spherocytosis: Linking Ion Transport Defects to Osmotic Gradient Ektacytometry Profiles—A Review

  2026cites this paper
• La revue du Comité SFAR Jeunes : « Prise en charge de la douleur aiguë : exemple du patient drépanocytaire »

  2026cites this paper
• Le globule rouge drépanocytaire : données fonctionnelles

  2023cites this paper
• Mouse models of sickle cell disease: Imperfect and yet very informative.

  2023cites this paper
• Zinc, Magnesium, and Copper Levels in Patients with Sickle Cell Disease: A Systematic Review and Meta-analysis

  2022cites this paper
• A importância do diagnóstico precoce e os tratamentos apresentados na Anemia Falciforme: Revisão Sistemática

  2022cites this paper
• Regional anesthesia for sickle cell disease vaso‐occlusive crisis: A single‐center case series

  2022cites this paper
• Migraine and rare neurological disorders

  2020cites this paper
• Association between Serum Ferritin and Blood Lipids: Influence of Diabetes and hs-CRP Levels

  2020cites this paper
• Analgesic management of uncomplicated acute sickle-cell pain crisis in pediatrics: a systematic review and meta-analysis

  2019cites this paper
• Sickle Cell Disease

  2019cites this paper
• Magnesium for treating sickle cell disease.

  2019cites this paper
• Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease

  2019cites this paper
• Combined genetic disruption of K-Cl cotransporters and Gardos channel KCNN4 rescues erythrocyte dehydration in the SAD mouse model of sickle cell disease.

  2019cites this paper
• Association between serum magnesium and blood lipids: influence of type 2 diabetes and central obesity

  2018cites this paper
• Red Blood Cell and Serum Magnesium Levels Among Children and Adolescents With Sickle Cell Anemia

  2018cites this paper
• Association between serum magnesium and blood count: influence of type 2 diabetes and central obesity

  2018cites this paper
• Corrected: The Role of Non-genetic Therapies to Reduce the Incidence of Sickle Cell Crisis: A Systematic Review

  year unknowncites this paper